Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy

Clinical Chemistry

Volumn 59, Issue 3, 2013, Pages 566-569

  Liebetrau, Christoph ^a,b   Nef, Holger ^a,b   Szardien, Sebastian ^a   Dörr, Oliver ^a,b   Willmer, Matthias ^a   Voss, Sandra ^a   Troidl, Christian ^a   Hoffmann, Jedrzej ^a   Rixe, Johannes ^a,b   Rolf, Andreas ^a,b  

^a Kerckhoff Heart and Thorax Center ^*  (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COPEPTIN; CREATINE KINASE; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PRACTICE; CREATINE KINASE BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; HEART SURGERY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PERSONALIZED MEDICINE; THORAX PAIN; THROMBOSIS; TRANSCORONARY ABLATION OF SEPTAL HYPERTROPHY;

ABLATION TECHNIQUES; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CREATINE KINASE; FEMALE; GLYCOPEPTIDES; HEART SEPTUM; HUMANS; KINETICS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 84874591834     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.194001     Document Type: Article

References (19)

1. Backus BE, Six AJ, Kelder JH, Gibler WB, Moll FL, Doevendans PA. Risk scores for patients with chest pain: evaluation in the emergency department. Curr Cardiol Rev 2011;7:2-8.
2. Forberg JL, Henriksen LS, Edenbrandt L, Ekelund U. Direct hospital costs of chest pain patients attending the emergency department: a retrospective study. BMC Emerg Med 2006;6:6.
3. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent STsegment elevation of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011;32:2999-3054.
4. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
5. Weber M, Bazzino O, Estrada JLN, de Miguel R, Salzberg S, Fuselli JJ, et al. Improved diagnostic and prognostic performance of a new highsensitive troponin T assay in patients with acute coronary syndrome. Am Heart J 2011;162:81-8.
6. Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010; 56:642-50.
7. Shah SH, de Lemos JA. Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment. JAMA 2009;302:92-3.
8. Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-45.
9. Heeschen C, Hamm CW, Bruemmer J, Simoons ML, for the CAPTURE Investigators. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. J Am Coll Cardiol 2000;35:1535-42.
10. Kurz K, Giannitsis E, Becker M, Hess G, Zdunek D, Katus HA. Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome. Clin Res Cardiol 2011;100:209-15.
11. Khan SQ, Dhillon OS, Russel J, Struck J, Quinn PA, Morgenthaler NG, et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 2007;115:2103-10.
12. Giannitsis E, Kehayova T, Vafaie M, Katus HA. Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction. Clin Chem 2011; 57:1452-5.
13. Keller T, Tzikas S, Zeller T, Czyz E, Lillpopp L, Ojeda FM, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010;55:2096-106.
14. Morgenthaler NG. Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail 2010;16:S37-44.
15. Morgenthaler NG, Struck J, Alfonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006;52:112-9.
16. Morgenthalter NG, Muller B, Struck J, Bergmann A, Redl H, Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007;28:219-26.
17. Meissner J, Nef H, Darga J, Kovacs M, Weber M, Hamm C, et al. Endogenous stress response in Tako-Tsubo cardiomyopathy and acute myocardial infarction. Eur J Clin Invest 2011;41:964-70.
18. Liebetrau C, Moellmann H, Nef H, Szardien S, Rixe J, Troidl C, et al. Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem 2012; 58:1049-54.
19. Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009; 54:60-8.